VNDA - Vanda Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5717.73M
Enterprise Value 3580.61M
Trailing P/E -69.26
Forward P/E 1-88.89
PEG Ratio (5 yr expected) 1-2.37
Price/Sales (ttm)4.60
Price/Book (mrq)5.46
Enterprise Value/Revenue 33.72
Enterprise Value/EBITDA 6-139.91

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin -6.54%
Operating Margin (ttm)-7.13%
Management Effectiveness
Return on Assets (ttm)-3.37%
Return on Equity (ttm)-8.07%
Income Statement
Revenue (ttm)156.2M
Revenue Per Share (ttm)3.54
Quarterly Revenue Growth (yoy)16.70%
Gross Profit (ttm)121.31M
EBITDA -4.15M
Net Income Avi to Common (ttm)-10.21M
Diluted EPS (ttm)-0.23
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)137.12M
Total Cash Per Share (mrq)3.06
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.32
Book Value Per Share (mrq)2.93
Cash Flow Statement
Operating Cash Flow (ttm)-7.56M
Levered Free Cash Flow (ttm)17.31M

Trading Information

Stock Price History
Beta 0.62
52-Week Change 30.95%
S&P500 52-Week Change 319.09%
52 Week High 318.99
52 Week Low 312.70
50-Day Moving Average 317.38
200-Day Moving Average 315.71
Share Statistics
Avg Vol (3 month) 3565.24k
Avg Vol (10 day) 3451.16k
Shares Outstanding 544.86M
Float 39.63M
% Held by Insiders 12.54%
% Held by Institutions 188.44%
Shares Short 32M
Short Ratio 35.77
Short % of Float 34.59%
Shares Short (prior month) 31.93M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A